From a diagnostic point of view, NECs of our series were completely negative for SATB2, confirming the inconstant expression of this transcription factor in neuroendocrine neoplasms [12] and making SATB2 not useful as a differential marker between grade 4 ONBs and NEC. Here, SATB2 is linked to neuroendocrine carcinoma.